Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Catherine Burzik, Bill Ward


Becton, Dickinson has appointed Catherine Burzik to its board of directors. She was formerly the president of Applied Biosystems, before it was acquired by Life Technologies, and most recently was president, CEO, and director of Kinetic Concepts. Currently, she is chair of the board of directors of VitaPath Genetics, chair of the Canisius College board of trustees, a member of the board of directors of Canisius, and on the board of trustees of the Keck Graduate School of Applied Life Sciences. She holds a BS in mathematics from Canisius College and an MS in mathematics from the University of Buffalo.

ZS Genetics, a North Reading, Mass.-based next-generation sequencing startup, has appointed Bill Ward to president and chief operating officer. Ward was founder, president, and CEO of ALIS before Carl Zeiss acquired it. He was also founder of Micrion and Beam Technologies.

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.